Wintermantel T M, Berger S, Greiner E F, Schütz G
Molecular Biology of the Cell I, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Horm Metab Res. 2004 Jun;36(6):387-91. doi: 10.1055/s-2004-814567.
Functional genomic technologies, including artificial chromosome-based transgenesis and conditional gene targeting, allowed us to generate mouse models harboring genes with loss-of-function mutations, gain-of-function mutations, spatially and/or temporally restricted mutations, tissue-specific mutations, and function-selective mutations. This kind of "allelic series" for corticosteroid receptors in mouse models provides a very useful resource for the molecular understanding of corticosteroid function in vivo. These models will also support the identification of steroid receptor target genes in order to define a steroid signaling cascade in molecular terms. They provide opportunities for the identification of compounds that regulate steroid receptors in a tissue-specific and function-selective manner. For example, selective glucocorticoid receptor modulators preventing receptor dimerization and DNA binding can be expected to reduce osteoporotic and/or diabetogenic side effects, but to display partial or full anti-inflammatory potential. Thus, these mouse models will help to evaluate distinct steroid receptor functions for therapeutic intervention.
功能基因组技术,包括基于人工染色体的转基因技术和条件性基因打靶技术,使我们能够构建携带功能丧失性突变、功能获得性突变、空间和/或时间限制性突变、组织特异性突变以及功能选择性突变基因的小鼠模型。小鼠模型中这种皮质类固醇受体的“等位基因系列”为体内皮质类固醇功能的分子理解提供了非常有用的资源。这些模型还将有助于鉴定类固醇受体靶基因,以便从分子层面定义类固醇信号级联反应。它们为鉴定以组织特异性和功能选择性方式调节类固醇受体的化合物提供了机会。例如,有望通过选择性糖皮质激素受体调节剂来防止受体二聚化和DNA结合,从而减少骨质疏松和/或致糖尿病的副作用,但同时展现出部分或全部抗炎潜力。因此,这些小鼠模型将有助于评估不同的类固醇受体功能,以用于治疗干预。